THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
<p>The role of P2Y12 receptor blocker clopidogrel after the introduction into clinical practice of new, more powerful and stable operating drugs belonging to this class of antiplatelet agents is discussed. The advantages and disadvantages of each of the currently used antiplatelet drugs that b...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | http://klinitsist.abvpress.ru/index.php/Klin/article/view/109 |
| _version_ | 1828078954997612544 |
|---|---|
| author | S. R. Gilyarevsky A. G. Larin P. Y. Lopotovsky I. M. Kuzmina O. V. Baturina |
| author_facet | S. R. Gilyarevsky A. G. Larin P. Y. Lopotovsky I. M. Kuzmina O. V. Baturina |
| author_sort | S. R. Gilyarevsky |
| collection | DOAJ |
| description | <p>The role of P2Y12 receptor blocker clopidogrel after the introduction into clinical practice of new, more powerful and stable operating drugs belonging to this class of antiplatelet agents is discussed. The advantages and disadvantages of each of the currently used antiplatelet drugs that block the receptor P2Y12 are reviewed. On the basis of the analysis concludes that, despite the emergence of new antiplatelet agents clopidogrel, appears to be widely used for a long time in the treatment of patients with acute coronary syndrome and / or after coronary stenting. This is primarily due to the presence of large evidence base, and confirmation of safety of long-term therapy clopidogrel.</p> |
| first_indexed | 2024-04-11T02:53:39Z |
| format | Article |
| id | doaj.art-004802f7e7ff4d719616468e1e739729 |
| institution | Directory Open Access Journal |
| issn | 1818-8338 |
| language | Russian |
| last_indexed | 2024-04-11T02:53:39Z |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Klinicist |
| spelling | doaj.art-004802f7e7ff4d719616468e1e7397292023-01-02T15:38:01ZrusABV-pressKlinicist1818-83382014-07-015395102124THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTORS. R. Gilyarevsky0A. G. Larin1P. Y. Lopotovsky2I. M. Kuzmina3O. V. Baturina4Emergency Care Scientific-Research Institute named N.V. SklifosovskyEmergency Care Scientific-Research Institute named N.V. SklifosovskyEmergency Care Scientific-Research Institute named N.V. SklifosovskyEmergency Care Scientific-Research Institute named N.V. SklifosovskyEmergency Care Scientific-Research Institute named N.V. Sklifosovsky<p>The role of P2Y12 receptor blocker clopidogrel after the introduction into clinical practice of new, more powerful and stable operating drugs belonging to this class of antiplatelet agents is discussed. The advantages and disadvantages of each of the currently used antiplatelet drugs that block the receptor P2Y12 are reviewed. On the basis of the analysis concludes that, despite the emergence of new antiplatelet agents clopidogrel, appears to be widely used for a long time in the treatment of patients with acute coronary syndrome and / or after coronary stenting. This is primarily due to the presence of large evidence base, and confirmation of safety of long-term therapy clopidogrel.</p>http://klinitsist.abvpress.ru/index.php/Klin/article/view/109acute coronary syndromemyocardial infarctionclopidogrelantithrombotic agents |
| spellingShingle | S. R. Gilyarevsky A. G. Larin P. Y. Lopotovsky I. M. Kuzmina O. V. Baturina THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR Klinicist acute coronary syndrome myocardial infarction clopidogrel antithrombotic agents |
| title | THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR |
| title_full | THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR |
| title_fullStr | THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR |
| title_full_unstemmed | THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR |
| title_short | THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR |
| title_sort | role of clopidogrel in patients with acute coronary syndrome after the emergence of more powerful inhibitors of p2y12 receptor |
| topic | acute coronary syndrome myocardial infarction clopidogrel antithrombotic agents |
| url | http://klinitsist.abvpress.ru/index.php/Klin/article/view/109 |
| work_keys_str_mv | AT srgilyarevsky theroleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT aglarin theroleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT pylopotovsky theroleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT imkuzmina theroleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT ovbaturina theroleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT srgilyarevsky roleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT aglarin roleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT pylopotovsky roleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT imkuzmina roleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor AT ovbaturina roleofclopidogrelinpatientswithacutecoronarysyndromeaftertheemergenceofmorepowerfulinhibitorsofp2y12receptor |